August 01, 2020
Article
A shorter course of pulmonary rehabilitation, with phone support, improved symptoms and reduced hospital readmissions for patients with post-acute exacerbation in chronic obstructive pulmonary disease (AECOPD).
July 31, 2020
Article
Using data from 2 phase 2 trials, researchers were able to determine the peak inspiratory flow (PIF) repeatability limit, and show that the 2 highest of 3 PIF values met the repeatedly limit.
July 24, 2020
Article
The health burden of comorbid chronic obstructive pulmonary disease (COPD) and asthma is known to be greater than when either condition exists on its own. An upcoming study shows that COPD is linked with greater all-cause mortality and greater risk of mortality in patients with coexisting asthma who also had long-term use of corticosteroids.
July 18, 2020
Article
A recent review discussed how to manage comorbid cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD).
July 17, 2020
Article
Using composite endpoints to predict clinically important deterioration in chronic obstructive pulmonary disease (COPD) could help investigators assess disease activity in clinical trials and better manage individual patients, according to a recent study.
July 11, 2020
Article
The focus on curbing COPD prevalence has largely focused on smoking cessation, but there are other factors, including diet, that can contribute to the risk of developing COPD.
July 05, 2020
Article
Results showed that living in a disadvantaged neighborhood is associated with worse COPD-related individual-level outcomes.
July 03, 2020
Article
Lung cancer screening by low-dose computed tomography does not examine spirometry in eligible patients, but study findings published this week suggest that adding this feature could improve the high burden of undiagnosed chronic obstructive pulmonary disease (COPD) and emphysema.
July 01, 2020
Article
The investigators conducted the study to understand more about the influence of each predictive factor of mortality in chronic obstructive pulmonary disease (COPD), as rates of death from the pulmonary disease have risen worldwide.
June 24, 2020
Article
A trial of 2 doses of an inhaled glucocorticoid in a fixed-dose triple therapy for chronic obstructive pulmonary disease (COPD) appeared beneficial compared with 1 of 2 dual therapies.